Equipment manufacturers in Canada aren’t using the SR&ED tax credit nearly as much as they should. Why? The answer comes down to the difference between an “intuition” and a “hypothesis.”
Topic: Scientific Research and Experimental Development
Submissions to the House of Commons Standing Committee on Finance (FINA) in advance of Budget 2019 seek better R&D tax credits, more space investments, and a bigger Strategic Innovation Fund, among other things.
Pfizer Canada has contributed $800,000 to MaRS Innovation to support new ideas or technologies in health sciences research in areas of therapeutics, diagnostic and treatment tools, and manufacturing technologies. The MaRS Innovation – Pfizer Translational Research Fund will be managed by MaRS Innovation. Priority projects are in cardiovascular disease, inflammation, immunology, rare diseases, vaccines, and…